TY - JOUR AU - Chen, N. AU - Zhou, M. AU - Dong, X. AU - Qu, J. AU - Gong, F. AU - Han, Y. PY - 2020 DA - 2020// TI - Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30211-7 DO - 10.1016/S0140-6736(20)30211-7 ID - Chen2020 ER - TY - JOUR AU - Shen, C. AU - Wang, Z. AU - Zhao, F. AU - Yang, Y. AU - Li, J. AU - Yuan, J. PY - 2020 DA - 2020// TI - Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma JO - JAMA VL - 323 UR - https://doi.org/10.1001/jama.2020.4783 DO - 10.1001/jama.2020.4783 ID - Shen2020 ER - TY - JOUR AU - Duan, K. AU - Liu, B. AU - Li, C. AU - Zhang, H. AU - Yu, T. AU - Qu, J. PY - 2020 DA - 2020// TI - Effectiveness of convalescent plasma therapy in severe COVID-19 patients JO - Proc Natl Acad Sci U S A VL - 117 UR - https://doi.org/10.1073/pnas.2004168117 DO - 10.1073/pnas.2004168117 ID - Duan2020 ER - TY - STD TI - Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, et al. Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection. Chest. 2020. https://doi.org/10.1016/j.chest.2020.03.039. ID - ref4 ER - TY - STD TI - Zeng QL, Yu ZJ, Gou JJ, Li GM, Ma SH, Zhang GF, et al. Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients. J Infect Dis. 2020. https://doi.org/10.1093/infdis/jiaa228. ID - ref5 ER - TY - STD TI - Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of Hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa237. ID - ref6 ER -